𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to: Circulating Tumor Cells and Detection of Melanoma-Associated Antigen HMW-MAA in the Serum of Melanoma Patients

✍ Scribed by Reynolds, Sandra R; Ferrone, Soldano; Bystryn, Jean-Claude


Book ID
110049233
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
35 KB
Volume
126
Category
Article
ISSN
0022-202X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cytoplasmic melanoma-associated antigen
✍ Sandra R. Reynolds; Irene J. Vergilis; Michael Szarek; Soldano Ferrone; Jean-Cla 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB

## Abstract Simple, noninvasive methods are needed to follow effectiveness of new treatments in patients with melanoma. In our study, we examined cytoplasmic melanoma‐associated antigen (CYT‐MAA) serum level in melanoma patients during immunotherapy. Sera of 117 patients were assayed for CYT‐MAA by

Suppression of human melanoma tumor grow
✍ Christine Hafner; Heimo Breiteneder; Soldano Ferrone; Christiane Thallinger; Ste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB

## Abstract The lack of efficacy of available therapies for the treatment of malignant melanoma has emphasized the need to develop novel therapeutic strategies to prevent melanoma growth. We have tested whether the anti‐HMW‐MAA mAb 225.28S is able to inhibit human melanoma tumor growth in SCID mice

Characterization of a 90-100 kDa tumor-a
✍ David M. Euhus; Rishab K. Gupta; Donald L. Morton 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 694 KB

## Abstract Using allogeneic antibody, we previously described a highmolecular‐weight glycoprotein in the urine of 68% of melanoma patients. This glycoprotein has been termed urinarytumor‐associated antigen (U‐TAA). A murine monoclonal antibody (MAb) specific for U‐TAA (AD1‐40F4) has been developed